Atyr Pharma Stock Return On Equity
ATyr Pharma fundamentals help investors to digest information that contributes to ATyr Pharma's financial success or failures. It also enables traders to predict the movement of ATyr Stock. The fundamental analysis module provides a way to measure ATyr Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ATyr Pharma stock.
ATyr |
ATyr Pharma Company Return On Equity Analysis
ATyr Pharma's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current ATyr Pharma Return On Equity | -0.56 |
Most of ATyr Pharma's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ATyr Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, ATyr Pharma has a Return On Equity of -0.5561. This is 97.68% lower than that of the Biotechnology sector and 98.47% lower than that of the Health Care industry. The return on equity for all United States stocks is 79.39% higher than that of the company.
ATyr Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ATyr Pharma's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ATyr Pharma could also be used in its relative valuation, which is a method of valuing ATyr Pharma by comparing valuation metrics of similar companies.ATyr Pharma is currently under evaluation in return on equity category among its peers.
ATyr Fundamentals
Return On Equity | -0.56 | |||
Return On Asset | -0.29 | |||
Operating Margin | (70.79) % | |||
Current Valuation | 55.05 M | |||
Shares Outstanding | 69.01 M | |||
Shares Owned By Insiders | 2.61 % | |||
Shares Owned By Institutions | 61.69 % | |||
Number Of Shares Shorted | 343.41 K | |||
Price To Earning | (2.19) X | |||
Price To Book | 1.30 X | |||
Price To Sales | 334.89 X | |||
Revenue | 353 K | |||
Gross Profit | (32.42 M) | |||
EBITDA | (52.18 M) | |||
Net Income | (50.39 M) | |||
Cash And Equivalents | 88.55 M | |||
Cash Per Share | 3.09 X | |||
Total Debt | 15.1 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 10.08 X | |||
Book Value Per Share | 1.24 X | |||
Cash Flow From Operations | (33.22 M) | |||
Short Ratio | 0.60 X | |||
Earnings Per Share | (0.88) X | |||
Target Price | 24.6 | |||
Number Of Employees | 56 | |||
Beta | 1.19 | |||
Market Capitalization | 131.12 M | |||
Total Asset | 122.07 M | |||
Retained Earnings | (468.02 M) | |||
Working Capital | 86.58 M | |||
Current Asset | 97.95 M | |||
Current Liabilities | 12.15 M | |||
Net Asset | 122.07 M |
About ATyr Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ATyr Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATyr Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATyr Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in ATyr Stock
If you are still planning to invest in ATyr Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATyr Pharma's history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |